BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16392801)

  • 1. Rational design and enantioselective synthesis of (1R,4S,5R,6S)-3-azabicyclo[3.3.0]octane-4,6-dicarboxylic acid - a novel inhibitor at human glutamate transporter subtypes 1, 2, and 3.
    Bunch L; Nielsen B; Jensen AA; Bräuner-Osborne H
    J Med Chem; 2006 Jan; 49(1):172-8. PubMed ID: 16392801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists.
    Nakazato A; Kumagai T; Sakagami K; Yoshikawa R; Suzuki Y; Chaki S; Ito H; Taguchi T; Nakanishi S; Okuyama S
    J Med Chem; 2000 Dec; 43(25):4893-909. PubMed ID: 11123999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid: a novel conformationally restricted glutamic acid analogue.
    Bunch L; Liljefors T; Greenwood JR; Frydenvang K; Bräuner-Osborne H; Krogsgaard-Larsen P; Madsen U
    J Org Chem; 2003 Feb; 68(4):1489-95. PubMed ID: 12585893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).
    Rorick-Kehn LM; Johnson BG; Burkey JL; Wright RA; Calligaro DO; Marek GJ; Nisenbaum ES; Catlow JT; Kingston AE; Giera DD; Herin MF; Monn JA; McKinzie DL; Schoepp DD
    J Pharmacol Exp Ther; 2007 Apr; 321(1):308-17. PubMed ID: 17204749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biology of the conformationally restricted ACPD analogue, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist.
    Kozikowski AP; Steensma D; Araldi GL; Tückmantel W; Wang S; Pshenichkin S; Surina E; Wroblewski JT
    J Med Chem; 1998 May; 41(10):1641-50. PubMed ID: 9572889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
    Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
    J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, theoretical and structural analyses, and enantiopharmacology of 3-carboxy homologs of AMPA.
    Brehm L; Greenwood JR; Sløk FA; Holm MM; Nielsen B; Geneser U; Stensbøl TB; Bräuner-Osborne H; Begtrup M; Egebjerg J; Krogsgaard-Larsen P
    Chirality; 2004 Aug; 16(7):452-66. PubMed ID: 15236343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel pyrrolo[3,4-d]pyrazole-dicarboxylic acids and evaluation of their interaction with glutamate receptors.
    Conti P; di Ventimiglia SJ; Pinto A; Tamborini L; Menniti FS; Lazzaro JT; De Micheli C
    Chem Biodivers; 2008 Apr; 5(4):657-63. PubMed ID: 18421758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology.
    Brehm L; Greenwood JR; Hansen KB; Nielsen B; Egebjerg J; Stensbøl TB; Bräuner-Osborne H; Sløk FA; Kronborg TT; Krogsgaard-Larsen P
    J Med Chem; 2003 Apr; 46(8):1350-8. PubMed ID: 12672235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of (4R)-alkyl glutamate analogues at the ionotropic glutamate receptors--focus on subtypes iGlu(5-7).
    Bunch L; Gefflaut T; Alaux S; Sagot E; Nielsen B; Pickering DS
    Eur J Pharmacol; 2009 May; 609(1-3):1-4. PubMed ID: 19285062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
    Conti P; De Amici M; Joppolo Di Ventimiglia S; Stensbøl TB; Madsen U; Bräuner-Osborne H; Russo E; De Sarro G; Bruno G; De Micheli C
    J Med Chem; 2003 Jul; 46(14):3102-8. PubMed ID: 12825948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, total synthesis, and biological evaluation of neodysiherbaine A derivative as potential probes.
    Sasaki M; Tsubone K; Shoji M; Oikawa M; Shimamoto K; Sakai R
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5784-7. PubMed ID: 16949819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-hydroxy-1,2,5-oxadiazol-3-yl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and molecular pharmacological characterization at ionotropic glutamate receptors of compounds related to glutamate and its homologues.
    Lolli ML; Giordano C; Pickering DS; Rolando B; Hansen KB; Foti A; Contreras-Sanz A; Amir A; Fruttero R; Gasco A; Nielsen B; Johansen TN
    J Med Chem; 2010 May; 53(10):4110-8. PubMed ID: 20408529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise Asymmetric Synthesis and Pharmacological Characterization of All Stereoisomers of Glutamate Transporter Inhibitor TFB-TBOA and Synthesis of EAAT Photoaffinity Probes.
    Leuenberger M; Ritler A; Simonin A; Hediger MA; Lochner M
    ACS Chem Neurosci; 2016 May; 7(5):534-9. PubMed ID: 26918289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoenzymatic Synthesis and Pharmacological Characterization of Functionalized Aspartate Analogues As Novel Excitatory Amino Acid Transporter Inhibitors.
    Fu H; Zhang J; Tepper PG; Bunch L; Jensen AA; Poelarends GJ
    J Med Chem; 2018 Sep; 61(17):7741-7753. PubMed ID: 30011368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series.
    Hiebel AC; Lee YS; Bilsky E; Giuvelis D; Deschamps JR; Parrish DA; Aceto MD; May EL; Harris LS; Coop A; Dersch CM; Partilla JS; Rothman RB; Cheng K; Jacobson AE; Rice KC
    J Med Chem; 2007 Aug; 50(16):3765-76. PubMed ID: 17625813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantioselective total synthesis of (1R,3S,4R,5R)-1-amino-4,5-dihydroxycyclopentane-1,3-dicarboxylic acid. A full-aldol access to carbaketose derivatives.
    Battistini L; Curti C; Zanardi F; Rassu G; Auzzas L; Casiraghi G
    J Org Chem; 2004 Apr; 69(7):2611-3. PubMed ID: 15049672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Alkylated homoibotenic acid (HIBO) analogues: versatile pharmacological agents with diverse selectivity profiles towards metabotropic and ionotropic glutamate receptor subtypes.
    Madsen U; Pickering DS; Nielsen B; Bräuner-Osborne H
    Neuropharmacology; 2005; 49 Suppl 1():114-9. PubMed ID: 15996690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantioselective Synthesis of (-)-Dysiherbaine.
    Do H; Kang CW; Cho JH; Gilbertson SR
    Org Lett; 2015 Aug; 17(16):3972-4. PubMed ID: 26258884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective agonists at group II metabotropic glutamate receptors: synthesis, stereochemistry, and molecular pharmacology of (S)- and (R)-2-amino-4-(4-hydroxy[1,2,5]thiadiazol-3-yl)butyric acid.
    Clausen RP; Bräuner-Osborne H; Greenwood JR; Hermit MB; Stensbøl TB; Nielsen B; Krogsgaard-Larsen P
    J Med Chem; 2002 Sep; 45(19):4240-5. PubMed ID: 12213064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.